Created at 3:39 a.m. May, 21, 2025
Author: kbshorts
Related Note: 1474580874963 2
Rationale for change

This card should clarify that it speaks about asthma. in COPD a LABA + LAMA would only be combined with ICS with easinophiles above 300 in most cases.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::02_Chronic_Asthma_Management #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::05_Treatment_of_COPD_and_Asthma #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::05_Asthma_drugs #AK_Step1_v12::#OME::PreClinical::General_Physiology::Smooth_Muscle #AK_Step2_v12::#Bootcamp::Medicine::02_Pulmonary_and_Critical_Care::01_Obstructive_Lung_Diseases::04_Chronic_Asthma_Management #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::15_beta-blockers::02_Selectivity::*B_Agonists::B2_Agonists::Long_Acting #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::02_Allergy_&_Pulmonary::02_Asthma_Therapy #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::06_Asthma_Treatment #AK_Step1_v12::#NinjaNerd::15_Respiratory::03_Pathology::13_COPD #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#SketchyIM::03_Pulmonology::09_Retired_Lessons::02_Obstructive_Pulmonary_Diseases::05_COPD_SOAP_[OLD_VERSION] #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::04_Albuterol_vs_Salmeterol #AK_Step1_v12::#Bootcamp::Pulmonology::05_Obstructive_Lung_Disease::03_Asthma_Treatments #AK_Step1_v12::#NinjaNerd::15_Respiratory::03_Pathology::09_Asthma #AK_Step1_v12::#AMBOSS::eOaxrk #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::05_Asthma_drugs::01_Inhaled_beta_2_-agonists::*Long_Acting_B2_Agonists #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::04_COPD_Treatment #PANCE::EOR::PEDS #AK_Step1_v12::^Systems::Respiratory::Pharmacology #AK_Step2_v12::#FirstAid::14_Pulm::01_Obstructive_Lung_Disease::02_Asthma #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::07_COPD_Management #AK_Step2_v12::#Bootcamp::Medicine::02_Pulmonary_and_Critical_Care::01_Obstructive_Lung_Diseases::02_Acute_Asthma_Management #AK_Step2_v12::!Shelf::EM #AK_Step2_v12::#Bootcamp::Medicine::02_Pulmonary_and_Critical_Care::01_Obstructive_Lung_Diseases::07_Chronic_COPD_Management